Periprocedural nebivolol for the prevention of contrast-induced acute kidney injury: A systematic review and meta-analysis

Conclusions: Despite no statistical significance, there was a trend toward reduced CIAKI risk in patients receiving nebivolol. The findings of our meta-analysis suggest the need of a large RCT with very careful attention to the balance of benefits and harms.

Source: North American Journal of Medical Sciences - October 30, 2015 Category: Journals (General) Authors: Natanong ThamcharoenCharat ThongprayoonPeter J EdmondsWisit Cheungpasitporn Source Type: research